Key result
Cardiac computed tomography has become an essential adjunct to echocardiography for evaluating valvular heart disease, particularly in planning transcatheter interventions and assessing complications.
Why the study?
The burden of valvular heart disease is increasing, and advances in cardiac computed tomography now provide novel insights alongside echocardiography, particularly for transcatheter valvular interventions.
Cardiac CT provides critical anatomical and procedural insights for the management of valvular heart disease, particularly in planning transcatheter interventions.
Supports CT integration in VHD planning; extends observational literature but leaves prospective outcome trials open.
The incidence and prevalence of valvular heart disease (VHD) is increasing and has been described as the next cardiac epidemic. Advances in imaging and therapeutics have revolutionized how we assess and treat patients with VHD. Although echocardiography continues to be the first-line imaging modality to assess the severity and the effects of VHD, advances in cardiac computed tomography (CT) now provide novel insights into VHD. Transcatheter valvular interventions rely heavily on CT guidance for procedural planning, predicting and detecting complications, and monitoring prosthesis. This review focuses on the current role and future prospects of CT in the assessment of aortic and mitral valves for transcatheter interventions, prosthetic valve complications such as thrombosis and endocarditis, and assessment of the myocardium.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2022) conducted a review in Valvular heart disease. Cardiac Computed Tomography was evaluated. Cardiac computed tomography has become an essential adjunct to echocardiography for evaluating valvular heart disease, particularly in planning transcatheter interventions and assessing complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: